Logo

Nautilus Biotechnology, Inc.

NAUT

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washingto… read more

Healthcare

Biotechnology

5 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$1.94

Price

0.00%

$0.00

Market Cap

$245.032m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$0.00

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$62.814m

+11.3%

1y CAGR

-3.3%

3y CAGR

-6.2%

5y CAGR
EPS

-$0.50

+10.7%

1y CAGR

-3.3%

3y CAGR

+3.3%

5y CAGR
Book Value

$169.139m

$200.915m

Assets

$31.776m

Liabilities

$27.003m

Debt
Debt to Assets

13.4%

-0.5x

Debt to EBITDA
Free Cash Flow

-$53.917m

+12.0%

1y CAGR

-4.5%

3y CAGR

-7.4%

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases